摘要
目的了解2015-2021年CHINET儿童患者分离的肠杆菌目细菌的分布及耐药性变迁。方法采用纸片扩散法或商品化药敏试验自动测试仪器法按照CHINET技术方案进行药敏试验,并采用CLSI 2021年版标准判断结果。结果2015-2021年共收到儿童患者分离的肠杆菌目细菌81681株,占儿童革兰阴性杆菌的50.1%,其中大肠埃希菌、克雷伯菌属和肠杆菌属是最常见的细菌;菌株主要分离自尿液标本(29.3%)和呼吸道标本(27.7%)。儿童大肠埃希菌、肺炎克雷伯菌和奇异变形杆菌的ESBL检出率分别为48.8%~57.6%、49.3%~66.7%和23.1%~33.8%。儿童碳青霉烯类耐药肠杆菌目细菌的检出率为5.7%~9.5%,呈下降趋势,其中碳青霉烯类耐药克雷伯菌属、碳青霉烯类耐药肠杆菌属和碳青霉烯类耐药大肠埃希菌的检出率分别为14.1%~22.6%、7.1%~15.7%和2.0%~3.4%。肠杆菌目细菌对环丙沙星的耐药率高于左氧氟沙星;对阿米卡星、多黏菌素B和替加环素仍具有较好的敏感性。沙门菌属对氨苄西林耐药率>70%,而对头孢曲松耐药率<30%。结论儿童患者分离的肠杆菌目部分细菌(如大肠埃希菌、肺炎克雷伯菌)对常见抗菌药物耐药率呈下降趋势,但需加强细菌耐药性的持续监测,以预防和控制耐药菌的广泛播散。
Objective To summarize the changing distribution and antimicrobial resistance profiles of Enterobacterales strains isolated from children in CHINET Antimicrobial Resistance Surveillance Program from 2015 to 2021.Methods Antimicrobial susceptibility testing was carried out according to a unified protocol using Kirby-Bauer method or automated systems.Results were analyzed according to CLSI 2021 breakpoints.Results A total of 81681 strains isolated from children were collected from 2015 to 2021,accounting for 50.1%of gram-negative isolates from children.The most frequently isolated species were Escherichia coli,Klebsiella spp.and Enterobacter spp..The main source of the isolates was urine and respiratory tract,accounting for 29.3%and 27.7%,respectively.The prevalence of extended-spectrumβ-lactamase in E.coli,Klebsiella pneumoniae and Proteus mirabilis was 48.8%-57.6%,49.3%-66.7%,and 23.1%-33.8%,respectively.The prevalence of carbapenem-resistant Enterobacterales was 5.7%-9.5%,with a decreasing trend over the 7-year period.The prevalence of carbapenem-resistant Klebsiella spp.,carbapenemresistant Enterobacter spp.,and carbapenem-resistant E.coli was 14.1%-22.6%,7.1%-15.7%,and 2.0%-3.4%,respectively.The Enterobacterales showed higher resistance rates to ciprofloxacin compared to levofloxacin.The Enterobacterales strains were still highly susceptible to amikacin,polymyxin B,and tigecycline.More than 70%of the Salmonella spp.strains were resistant to ampicillin,while lower than 30%of these strains were ressitant to ceftriaxone.Conclusions Some Enterobacterales species isolated from children such as E.coli and K.pneumoniae showed decreasing resistance to commonly used antimicrobial agents.However,continuous monitoring of bacterial resistance should be strengthened in order to prevent and control the spread of drugresistant bacteria.
作者
潘芬
王春
张泓
杨洋
胡付品
朱德妹
蒋晓飞
徐英春
张小江
张峰波
季萍
谢轶
康梅
王传清
付盼
徐元宏
黄颖
孙自镛
陈中举
倪语星
孙景勇
褚云卓
田素飞
胡志东
李金
俞云松
林洁
单斌
杜艳
郭素芳
魏莲花
邹凤梅
胡云建
艾效曼
卓超
苏丹虹
郭大文
赵金英
喻华
黄湘宁
刘文恩
李艳明
金炎
邵春红
徐雪松
鄢超
王山梅
楚亚菲
张利侠
马娟
周树平
周艳
朱镭
孟晋华
董方
吕志勇
胡芳芳
沈瀚
周万青
贾伟
李刚
吴劲松
卢月梅
李继红
段金菊
康建邦
马晓波
郑燕青
郭如意
朱焱
陈运生
孟青
王世富
胡雪飞
沈继录
黄文辉
汪瑞忠
房华
俞碧霞
赵勇
龚萍
温开镇
张贻荣
刘江山
廖龙凤
顾洪芹
姜琳
贺雯
薛顺虹
冯佼
岳春雷
PAN Fen;WANG Chun;ZHANG Hong;YANG Yang;HU Fupin;ZHU Demei;JIANG Xiaofei;XU Yingchun;ZHANG Xiaojiang;ZHANG Fengbo;JI Ping;XIE Yi;KANG Mei;WANG Chuanqing;FU Pan;XU Yuanhong;HUANG Ying;SUN Ziyong;CHEN Zhongju;NI Yuxing;SUN Jingyong;CHU Yunzhuo;TIAN Sufei;HU Zhidong;LI Jin;YU Yunsong;LIN Jie;SHAN Bin;DU Yan;GUO Sufang;WEI Lianhua;ZOU Fengmei;HU Yunjian;AI Xiaoman;ZHUO Chao;SU Danhong;GUO Dawen;ZHAO Jinying;YU Hua;HUANG Xiangning;LIU Wen’en;LI Yanming;JIN Yan;SHAO Chunhong;XU Xuesong;YAN Chao;WANG Shanmei;CHU Yafei;ZHANG Lixia;MA Juan;ZHOU Shuping;ZHOU Yan;ZHU Lei;MENG Jinhua;DONG Fang;LÜZhiyong;HU Fangfang;SHEN Han;ZHOU Wanqing;JIA Wei;LI Gang;WU Jinsong;LU Yuemei;LI Jihong;DUAN Jinju;KANG Jianbang;MA Xiaobo;ZHENG Yanqing;GUO Ruyi;ZHU Yan;CHEN Yunsheng;MENG Qing;WANG Shifu;HU Xuefei;SHEN Jilu;HUANG Wenhui;WANG Ruizhong;FANG Hua;YU Bixia;ZHAO Yong;GONG Ping;WEN Kaizhen;ZHANG Yirong;LIU Jiangshan;LIAO Longfeng;GU Hongqin;JIANG Lin;HE Wen;XUE Shunhong;FENG Jiao;YUE Chunlei(Department of Clinical Laboratory,Shanghai Children’s Hospital,School of Medicine,Shanghai Jiao Tong University,Institute of Pediatric Infection,Immunity,and Critical Care Medicine,Shanghai Jiao Tong University School of Medicine,Shanghai,China,200062)
出处
《中国感染与化疗杂志》
CAS
CSCD
北大核心
2024年第1期53-63,共11页
Chinese Journal of Infection and Chemotherapy
基金
CHINET中国细菌耐药监测网基金(2020QD049)
上海市临床重点专科建设项目(shslczdzk06902)
上海市“医苑新星”青年医学人才培养资助计划—青年医学人才类—临床检验项目。